Takeda and Noile-Immune Biotech Collaborate to Advance Next Generation CAR-T Cell Therapy Effective for Solid …PharmiWeb.com (press release)The next generation CAR-T cell therapy was developed by Professor Koji Tamada at Yamaguchi University and Noil… Continue reading
|
Global Updated Gene Therapy Technologies, Markets and …
Business Wire (press release) The “Gene Therapy – Technologies, Markets and Companies” report from Jain PharmaBiotech has been added to Research and Markets’ offering. Th. |
KCUR |
Shawnee Woman Was Among First In The World To Undergo New FDA-Approved Cancer Therapy
KCUR CAR: It’s a mouthful, but it stands for chimeric antigen receptors. The therapy involves removing a patient’s T cells, a type of white blood cell, and genetically engineering them to recognize and attack the patient’s tumors. The T cells are then put … |
PR Web |
Stem Cell Assay Market – Industry Analysis, Size, Share, Growth, Trends, and Outlook to 2025
Medgadget (blog) Stem cell assay refers to the procedure of measuring the potency of antineoplastic drugs, on the basis of their capability of retarding the growth of human tumor cells. The assay consists of qualitative or quantitative analysis or testing of affected … Robert Russell Named Director of Physician Engagement at Okyanos Center for Regenerative MedicinePR Web (press release) |
Labiotech.eu (blog) |
The CAR–T Race is Far from Over: This CEO is Exploring a New Avenue
Labiotech.eu (blog) Gilead has just splashed out $12 billion for Kite Pharma, and Ihe FDA is currently reviewing Novartis’ Marketing Approval Application for the first-ever CAR–T therapy. I sat down with Gregg Sando of Cell Medica to hear the perspective of a biotech … |
Labiotech.eu (blog) |
The CAR–T Race is Far from Over: This CEO is Exploring a New Avenue
Labiotech.eu (blog) Gilead has just splashed out $12 billion for Kite Pharma, and Ihe FDA is currently reviewing Novartis’ Marketing Approval Application for the first-ever CAR–T therapy. I sat down with Gregg Sando of Cell Medica to hear the perspective of a biotech … |